Product
BMS-986156
2 clinical trials
6 indications
Indication
Solid TumorsIndication
Malignant NeoplasmIndication
Liver MetastasisIndication
Metastatic Carcinoma in the LungIndication
Metastatic Malignant Solid NeoplasmClinical trial
A Phase 1/2a Dose Escalation and Cohort Expansion Study for Safety, Tolerability, and Efficacy of BMS-986156 Administered Alone and in Combination With Nivolumab (BMS-936558, Anti PD-1 Monoclonal Antibody) in Advanced Solid TumorsStatus: Completed, Estimated PCD: 2019-12-16
Clinical trial
Phase I/II Trial of Ipilimumab or Nivolumab With BMS-986156 and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid MalignanciesStatus: Active (not recruiting), Estimated PCD: 2024-08-29